Education
About Us
Working with TipRanks
Follow Us
NAYA Biosciences (NAYA)
NASDAQ:NAYA
NAYA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.94 - $42.00
Previous CloseN/A
Volume42.13K
Average Volume (3M)29.59K
Market Cap
$1.82M
Enterprise ValueN/A
Total Cash (Recent Filing)$232.42K
Total Debt (Recent Filing)$6.30M
Price to Earnings (P/E)―
Beta-0.53
Next Earnings
Apr 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-30.54
Shares Outstanding666,058
10 Day Avg. Volume65,985
30 Day Avg. Volume29,588
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.29
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2.00Price Target Upside-17.01% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
NAYA Biosciences News
PremiumCompany Announcements
NAYA Biosciences Raises $9.5M Amid Nasdaq Compliance Issues---
Ownership Overview
―
Insiders
1.11% Mutual Funds
<0.01% Other Institutional Investors
98.22% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NAYA FAQ
What was NAYA Biosciences’s price range in the past 12 months?
NAYA Biosciences lowest stock price was $1.94 and its highest was $42.00 in the past 12 months.
What is NAYA Biosciences’s market cap?
NAYA Biosciences’s market cap is $1.82M.
When is NAYA Biosciences’s upcoming earnings report date?
NAYA Biosciences’s upcoming earnings report date is Apr 22, 2025 which is in 27 days.
How were NAYA Biosciences’s earnings last quarter?
Currently, no data Available
Is NAYA Biosciences overvalued?
According to Wall Street analysts NAYA Biosciences’s price is currently Overvalued.
Does NAYA Biosciences pay dividends?
NAYA Biosciences does not currently pay dividends.
What is NAYA Biosciences’s EPS estimate?
NAYA Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NAYA Biosciences have?
NAYA Biosciences has 666,058 shares outstanding.
What happened to NAYA Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NAYA Biosciences?
Currently, no hedge funds are holding shares in NAYA
---
Company Description
NAYA Biosciences
INVO Bioscience is a medical device company providing devices and products for infertility diagnosis. Its flagship product is INVOcell, a reproductive technology that allows fertilization and early embryo development to take place within the woman’s body.
---
NAYA Stock 12 Month Forecast
Average Price Target
$2.00
▼(-17.01% Downside)
Technical Analysis
Sangamo Biosciences
―
Bluebird Bio
―
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Best Analysts Covering NAYA
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-51.00%
upgraded a buy rating 2 months ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -51.00% per trade.
---